Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Stolte

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of Neurology|April 26, 2021
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parametersBenjamin Stolte, Michael Nonnemacher, Kathrin Kizina, et al.
Neurological Research and Practice|September 4, 2022
Essen transition model for neuromuscular diseasesMichael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Der Nervenarzt|March 7, 2022
[Essen transition model for neuromuscular diseases]Michael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Frontiers in Neurology|December 3, 2019
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular AtrophyKathrin Kizina, Benjamin Stolte, Andreas Totzeck, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophyBenjamin Stolte, Andreas Totzeck, Kathrin Kizina, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Journal of Clinical Immunology|June 12, 2023
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case ReportChristoph Oster, Benjamin Stolte, Livia Asan, et al.
Journal of Neurology|March 28, 2026
Correction: Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplamSvenja Neuhoff, Benjamin Stolte, Jaqueline Lipka, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|April 29, 2025
Impact of bridging intravenous thrombolysis and infarct core growth rate on early neurological improvement in patients with acute anterior circulation ischemic stroke and mechanical thrombectomyNatalie van Landeghem, Christoph Ziegenfuß, Aydin Demircioglu, et al.
Therapeutic Advances in Neurological Disorders|August 16, 2021
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM studyAndreas Totzeck, Elakiya Ramakrishnan, Melina Schlag, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of Neurology|April 26, 2021
Nusinersen treatment in adult patients with spinal muscular atrophy: a safety analysis of laboratory parametersBenjamin Stolte, Michael Nonnemacher, Kathrin Kizina, et al.
Neurological Research and Practice|September 4, 2022
Essen transition model for neuromuscular diseasesMichael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Der Nervenarzt|March 7, 2022
[Essen transition model for neuromuscular diseases]Michael Fleischer, Bayram Coskun, Benjamin Stolte, et al.
Frontiers in Neurology|December 3, 2019
Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular AtrophyKathrin Kizina, Benjamin Stolte, Andreas Totzeck, et al.
Therapeutic Advances in Neurological Disorders|October 12, 2018
Feasibility and safety of intrathecal treatment with nusinersen in adult patients with spinal muscular atrophyBenjamin Stolte, Andreas Totzeck, Kathrin Kizina, et al.
Eneurologicalsci|February 19, 2021
Detect it so you can treat it: A case series and proposed checklist to detect neurotoxicity in checkpoint therapySaskia Bolz, Thivyah Ramakrishnan, Michael Fleischer, et al.
Journal of Clinical Immunology|June 12, 2023
Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case ReportChristoph Oster, Benjamin Stolte, Livia Asan, et al.
Journal of Neurology|March 28, 2026
Correction: Matched-pair analysis of motor outcomes in adults with spinal muscular atrophy on nusinersen vs. risdiplamSvenja Neuhoff, Benjamin Stolte, Jaqueline Lipka, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|April 29, 2025
Impact of bridging intravenous thrombolysis and infarct core growth rate on early neurological improvement in patients with acute anterior circulation ischemic stroke and mechanical thrombectomyNatalie van Landeghem, Christoph Ziegenfuß, Aydin Demircioglu, et al.
Therapeutic Advances in Neurological Disorders|August 16, 2021
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM studyAndreas Totzeck, Elakiya Ramakrishnan, Melina Schlag, et al.
Pageof 4